Press Releases | Sandwalk Bioventures

Fecal Microbiota Transplantation (FMT): Global Industry and Regulatory Overview

First described in the 4th Century in China, practiced since the 1950’s and re-discovered relatively recently, Fecal Microbiota...

Monacolins restrictions coming up in Europe – Lower limits, label warnings and a lost health claim

On June 2nd, 2022, Regulation 2022/860 was published on the Official Journal of the European Union. This Regulation establishes a daily...

Sandwalk to sponsor and join the Pharmabiotics Event, April 20-21, 2022

Sandwalk BioVentures will proudly sponsor and join tens of microbiome companies at the Pharmabiotics Event, taking place on 20-21 of...

Sandwalk to present and actively participate in Probiota 2022 in Copenhagen

Luis Gosálbez, Managing Director and Co-Founder, will be presenting Sandwalk’s latest market analysis on postbiotics in food, feed,...

Sanofi to acquire skin microbiome drug developer biotech Origimm

French pharmaceutical giant Sanofi has inked the acquisition of Origimm Biotechnology GmbH, an Austrian biotech developing therapies...

Sandwalk's Bactheriophage Drug Development Report published on The Microbiome Times

We are pleased to announce that our Bactheriophage Drug Development Report is now available at the Microbiome Times. The report contains...